QMT-CBT is a near-infrared aggregation-induced luminescent photon. After activation of caspase1 (Cas1), QMT-CBT undergoes a CBT-Cys click reaction to form a cyclic dimer QMT-Dimer (the first aggregate) and assembles into nanoparticles (the second aggregate), turning the AIE signal on to enhance imaging of Alzheimers disease (AD)[1].
Molecular Weight:
1805.09
Formula:
C94H89N19O12S4
Target:
Biochemical Assay Reagents
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
